Dermatofibrosarcoma protuberans is a relatively uncommon soft tissue tumor involving the dermal layer of skin with intermediateto-low grade malignancy. Although metastasis rarely occurs, Dermatofibrosarcoma protuberans is a locally aggressive tumor with a high recurrence rate. We treated a 35-year-old male patient with Dermatofibrosarcoma protuberans left breast at Pakistan Air Force hospital Karachi. The reluctance on the patient's side unnecessarily delayed operative procedure. Allowing wide safety margins during resection, an extended resection was carried out. The patient was later subjected to radiotherapy.
Introduction
Dermatofi brosarcoma protuberans (DFSP) usually occurs in age groups between 20-50 years. It has rarely been reported in newborns and more elderly individuals. It was Hoffman, 1 and colleagues who endorsed the term 'Dermatofibrosarcoma protuberance' (DFSP) in medical literature in 1925, after modification of the existing word -dermatofibroma. The tumor appears as a very small nodule on the skin surface, it is composed of firm, irregular nodules varying in color, from flesh to reddish brown. It remains in the same shape for years, but then it undergoes a period of very rapid growth where many small nodules in the dermis form a larger, more noticeable mass. This mass starts bulging towards the epidermis, hence the term "protuberans," it may also present as a morphea-like, atrophic, sclerotic, and violaceous plaque without nodularity that may ulcerate as it slowly increases in size. Due to stretch and strain, it may turn into a weeping ulcer. It can invade fat, muscles and even bones. Distant metastasis is there but rare. DFSP most commonly occurs on the trunk, followed by the proximal extremities. It rarely occurs above the neck. Some cases of female breast involvement have been noticed, but involvement of the male breast is very, very rare. Surgical scars, old burns, contractures and sites of vaccinations have all been reported as DFSP sites.
2,3 Platelet-derived Growth factor (PDGF) increase response leads to increased formation of tumor cells by reciprocal translocations of chromosomes 17 and 22,t(17;22), and supernumerary ring chromosomes composed of interspersed sequences from bands 17(17q22) and 22(22q12). 4, 5 Treatment is primarily surgical, with chemotherapy and radiation therapy sometimes being used. There is clinical evidence that Imatinib, 6 which inhibits PDGFB, may be effective for tumors positive for the t(17; 22) translocation.
Case Report
A young male nurse presented with dark colored swelling on the outer upper quadrant of the left breast area. It was about 3.5x 2.5 cm, soft, non-adherent swelling. The regional lymph glands were not accessible. Ultrasound scan demarcated a soft tissue swelling with no cystic component, while FNAC revealed inadequate sampling; an incisional biopsy was advised in May 2008. A specimen measuring approximately 5 × 3-4 cm was sent for histopathology. It read as Dermatofibrosarcoma protuberans and wide local excision (WLE) was suggested but compliance from the patient was poor, despite repeated counseling. When he turned up at the surgical outpatient department after about nine months of follow up visit, he had already developed a huge swelling at a previous scar area, (Fig. 1) . At that time, the swelling was firm, measuring about 7.5 × 7 cm, but mobile. The regional glands were still not accessible and chest radiological examination was within normal limits. At this point, the patient consented for surgery. In March 2009, he underwent surgery and wide local excision (WLE), with up down stabbing of the skin to reduce tension while closure was carried out (Fig. 2) . Recovery was uneventful. Histopathology revealed monomorphous bland spindle cells arranged in a storiform or "herringbone" pattern. Immunohistochemical analysis showed staining for CD34, suggestive of recurrent DFSP breast left. Radiotherapy after detail discussion with oncologist, radiotherapist and histopathologist was done. The patient is currently engaged in his normal pursuits. 
Discussion
It was previously considered that DFSP does not present with any specific community, ethnic or geographical tendencies, but after reviewing the cancer cases from 1973 to 2002 by Criscione and Weinstock, 7 it was found that the annual incidence of DFSP in the United States is 4.2 per million cases per year, and was predominant in black males with a DFSP pigmentary variant Bednar tumor (6.5 cases per million), compared to white males (3.9 cases per million). 7 In another study by Rutgers et al. of 514 patients, 57% were males. 3 DFSP accounts for less than 0.1% of all malignant neoplasms and approximately 1% of all soft tissue sarcomas. In our study, it was noticed that this was the first case for the last five years in this hospital. It is commonly seen on the trunk of the body (chest, abdomen, and back) but can also occur on arms, legs, head, neck, hands, or feet. Few cases of female breast area involvement were reported, but involvement of male breast is less likely supported by medical literature. A recent case report by Cavusoglu and colleagues affirms that breast involvement even in female is a very rare incidence. 3 A study by Karcnik et al.
similarly advocated very little involvement of the breast. 8 DFSP is a very slowly growing tumor. Because of the slow progression, the diagnosis is often delayed, as in our case who reported for the first time after eight years of attaining the swelling. In our case, WLE was performed, including the breast with areola and nipple complex with direct closure by up down skin shearing to release tension; however, our Turkish counterpart Cavusoglu et al. also performed mammoplasty after excising the tumorous mass of the female breast. 9 Our patient also underwent radiotherapy to counter any residual cancerous tissue. Other modalities of treatment like Moh' s micrographic techniques can be extremely effective; it removes the tumor and all related pathological cells without a wide-area excision that may overlook sarcoma cells that have penetrated muscle tissue. As an alternative to WLE; Moh's micrographic surgery (MMS) is emerging as the treatment of choice for resection of large or recurrent DFSP, and those arising in anatomically challenging areas such as the head or neck. In contrast to WLE, which uses representative vertical sectioning; MMS requires continuing sequential horizontal sectioning during the resection with immediate microscopic examination of the resected tissue by frozen section until a clear margin is obtained. [10] [11] [12] In a pooled analysis of published series of DFSP treated with MMS (with many cases treated for recurrence after WLE) or WLE, the local recurrence rate averaged 1.5%. 12, 13 DFSP is a locally aggressive tumor with a high recurrence rate. Although metastasis of DFSP is rare (only 1-4% reported), almost all metastatic cases have been associated with local recurrence and poor prognosis. Most patients with metastatic DFSP died within two years. A small subset of DFSP patients present with fibrosarcomatous progression. This fibrosarcomatous progression DFSP variant is more aggressive in nature and the clinical outcome usually is poor. 14 
